We are live on
!
Find out more
DnB Asset Management Portfolio holdings
AUM
$28B
1-Year Est. Return
26%
This Fund
S&P 500
This Quarter
Est. Return
-4.57%
1 Year Est. Return
+26%
3 Year Est. Return
+97.1%
5 Year Est. Return
+115.87%
10 Year Est. Return
+443.63%
AUM
$21.7B
AUM Growth
-$1.42B
(-6.1%)
Cap. Flow
+$74.1M
Cap. Flow
% of AUM
0.34%
Top 10 Holdings %
Top 10 Hldgs %
37.96%
Holding
778
New
46
Increased
318
Reduced
356
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$323M |
| 2 |
Oracle
ORCL
|
+$303M |
| 3 |
SNDK
Sandisk
SNDK
|
+$244M |
| 4 |
Marvell Technology
MRVL
|
+$180M |
| 5 |
Booking.com
BKNG
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$355M |
| 2 |
Mastercard
MA
|
+$247M |
| 3 |
Electronic Arts
EA
|
+$222M |
| 4 |
Western Digital
WDC
|
+$221M |
| 5 |
Meta Platforms (Facebook)
META
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.89% |
| 2 | Communication Services | 13.62% |
| 3 | Financials | 12.74% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Healthcare | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
SoundHound AI
SOUN
$2.48B
| $539K | ﹤0.01% |
+66,372
| New | +$827K |
|
652
Caterpillar
CAT
$361B
| $528K | ﹤0.01% |
1,602
+66
| +4% | +$23.5K |
|
653
Ultragenyx Pharmaceutical
RARE
$2.46B
| $517K | ﹤0.01% |
14,268
+2,136
| +18% | +$88.9K |
|
654
Jefferies Financial Group
JEF
$12.7B
| $498K | ﹤0.01% |
9,305
+6,266
| +206% | +$425K |
|
655
CDW
CDW
$18.9B
| $493K | ﹤0.01% |
3,075
-21,812
| -88% | -$3.96M |
|
656
Roivant Sciences
ROIV
$23.6B
| $489K | ﹤0.01% |
48,479
+3,802
| +9% | +$41.1K |
|
657
Aehr Test Systems
AEHR
$2.13B
| $475K | ﹤0.01% |
65,207
+16,521
| +34% | +$183K |
|
658
Impinj
PI
$4.24B
| $475K | ﹤0.01% |
5,233
+1,297
| +33% | +$145K |
|
659
Viking Therapeutics
VKTX
$3.88B
| $471K | ﹤0.01% |
19,495
-11,171
| -36% | -$353K |
|
660
Amer Sports
AS
$21B
| $465K | ﹤0.01% |
17,405
| – | – |
|
|
SWTX
661
DELISTED
SpringWorks Therapeutics
SWTX
| $461K | ﹤0.01% |
10,444
-1,431
| -12% | -$65.9K |
|
662
Spire Global
SPIR
$408M
| $441K | ﹤0.01% |
54,506
-26,293
| -33% | -$348K |
|
663
XP
XP
$8.43B
| $438K | ﹤0.01% |
31,831
+3,665
| +13% | +$50.5K |
|
664
Vishay Intertechnology
VSH
$4.6B
| $434K | ﹤0.01% |
27,285
+6,013
| +28% | +$103K |
|
665
Navitas Semiconductor
NVTS
$2.54B
| $434K | ﹤0.01% |
211,575
-294,549
| -58% | -$844K |
|
666
Vipshop
VIPS
$7.26B
| $424K | ﹤0.01% |
27,037
| – | – |
|
667
Cytokinetics
CYTK
$10.6B
| $419K | ﹤0.01% |
10,434
+1,221
| +13% | +$56.1K |
|
668
Ryman Hospitality Properties
RHP
$8.56B
| $414K | ﹤0.01% |
+4,530
| New | +$455K |
|
669
Zurn Elkay Water Solutions
ZWS
$8.6B
| $405K | ﹤0.01% |
12,284
+1,517
| +14% | +$54.6K |
|
670
MoonLake Immunotherapeutics
MLTX
$1.56B
| $403K | ﹤0.01% |
10,311
+1,955
| +23% | +$84.2K |
|
671
Freshpet
FRPT
$3.04B
| $398K | ﹤0.01% |
+4,791
| New | +$586K |
|
672
Kratos Defense & Security Solutions
KTOS
$8.23B
| $394K | ﹤0.01% |
+13,278
| New | +$403K |
|
673
Mueller Water Products
MWA
$3.94B
| $392K | ﹤0.01% |
+15,425
| New | +$387K |
|
674
Element Solutions
ESI
$8.48B
| $387K | ﹤0.01% |
+17,114
| New | +$437K |
|
|
MRUS
675
DELISTED
Merus
MRUS
| $380K | ﹤0.01% |
+9,035
| New | +$394K |
|
Similar funds
N
PCH
TWC
FDCDDQ
NA
DnB Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, DnB Asset Management held 778 positions worth $21.7B, down 6.1% from $23.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
DnB Asset Management's Q1 2025 filing shows 46 new, 318 increased, 356 reduced and 40 closed positions. Its largest new stake was Sandisk: 4,906,280 shares worth $234M. The largest sale was Visa, an estimated $355M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Communication Services and Financials.
- DnB Asset Management's largest Q1 2025 buy was Sandisk: 4,906,280 shares worth $234M.
- DnB Asset Management added most to NVIDIA in Q1 2025, an estimated $323M increase.
- DnB Asset Management's biggest Q1 2025 reduction was Visa, cutting an estimated $355M.
- DnB Asset Management fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $7.31M.
- DnB Asset Management's ten largest holdings make up 38% of its $21.7B portfolio in Q1 2025.
- DnB Asset Management opened 46 new positions and closed 40 in Q1 2025.
- DnB Asset Management's portfolio value fell 6.1% quarter-over-quarter to $21.7B.
Based on DnB Asset Management's 13F filing for Q1 2025, filed 15 May 2025.